跳至主要内容
临床试验/IRCT2017070420258N51
IRCT2017070420258N51招募中2 期

Evaluation of intravenous pamidronate & oral alendronate on bone marrow density in ?patients with major and intermedia thalassemia

Vice chancellor for research, Arak University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10 years 至 139 years(—)
性别
All

入选标准

  • patients with major and inter media thalassemia ,age more than 10 years referred to Amir kabir hospital
  • Exclusion criteria: Gastrointestinal intolerance for oral medication; having an allergic drug; heart failure; liver failure; hypoparathyroidism

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Arak University of Medical Sciences

相似试验